A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
Clinical trial NCT00502840 · COMPLETED
Trial details
- NCT number
- NCT00502840
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-23
- Primary completion
- 2011-09-20
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.